Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Alexandre, Janel"'
Autor:
Stéphanie Maupetit‐Mehouas, Franck Court, Céline Bourgne, Agnès Guerci‐Bresler, Pascale Cony‐Makhoul, Hyacinthe Johnson, Gabriel Etienne, Philippe Rousselot, Denis Guyotat, Alexandre Janel, Eric Hermet, Sandrine Saugues, Juliette Berger, Philippe Arnaud, Marc G. Berger
Publikováno v:
Molecular Oncology, Vol 12, Iss 6, Pp 814-829 (2018)
Despite the high efficiency of tyrosine kinase inhibitors (TKI), some patients with chronic myeloid leukemia (CML) will display residual disease that can become resistant to treatment, indicating intraclonal heterogeneity in chronic‐phase CML (CP
Externí odkaz:
https://doaj.org/article/b9748f2553f944a0a5f7f0ba157e2821
Autor:
Nadine Cadoux, Alexandre Janel, Françoise Huguet, Franck E. Nicolini, Marc G. Berger, Pascale Flandrin-Gresta, Sandrine Hayette, Sandrine Saugues, Pascale Cohny-Makhoul, Denis Guyotat, Carole Colin-Gil, Lydia Campos, Alexis Genthon, Jean-Michel Cayuela
Publikováno v:
Oncotarget
Oncotarget, Impact journals, 2020, 11 (26), pp.2560-2570. ⟨10.18632/oncotarget.27652⟩
Oncotarget, Impact journals, 2020, 11 (26), pp.2560-2570. ⟨10.18632/oncotarget.27652⟩
Chronic myeloid leukemia (CML) is a myeloproliferative neoplasm characterized by the presence of BCR-ABL1 transcript as a result of reciprocal translocation between chromosome 9 and 22. The most common transcripts subtypes are e13a2 (b2a2) and e14a2
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5592de47ed7c6f39277f26bf424c8f89
https://hal.archives-ouvertes.fr/hal-02935852
https://hal.archives-ouvertes.fr/hal-02935852
Autor:
Philippe Rousselot, Eric Hermet, Marc G. Berger, Juliette Berger, Pascale Cony-Makhoul, Denis Guyotat, Franck Court, Stéphanie Maupetit-Mehouas, Gabriel Etienne, Alexandre Janel, Sandrine Saugues, Philippe Arnaud, Agnès Guerci-Bresler, Céline Bourgne, Hyacinthe Johnson
Publikováno v:
Molecular Oncology. 12:814-829
Despite the high efficiency of tyrosine kinase inhibitors (TKI), some patients with chronic myeloid leukemia (CML) will display residual disease that can become resistant to treatment, indicating intraclonal heterogeneity in chronic-phase CML (CP-CML
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7c8b0a1aa9b3691506bc57fdc354862c
https://doi.org/10.1002/1878-0261.12191
https://doi.org/10.1002/1878-0261.12191
Autor:
Alexis, Genthon, Franck Emmanuel, Nicolini, Françoise, Huguet, Carole, Colin-Gil, Marc, Berger, Sandrine, Saugues, Alexandre, Janel, Sandrine, Hayette, Pascale, Cohny-Makhoul, Nadine, Cadoux, Jean-Michel, Cayuela, Lydia, Campos, Denis, Guyotat, Pascale, Flandrin-Gresta
Publikováno v:
Oncotarget
Chronic myeloid leukemia (CML) is a myeloproliferative neoplasm characterized by the presence of BCR-ABL1 transcript as a result of reciprocal translocation between chromosome 9 and 22. The most common transcripts subtypes are e13a2 (b2a2) and e14a2
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::6c5d75d121293c8e9204e002a5625701
https://pubmed.ncbi.nlm.nih.gov/32655840
https://pubmed.ncbi.nlm.nih.gov/32655840
Autor:
Aurélie Briançon, Frédérique Lioret, Chantal Rapatel, Mahchid Bamdad, Nathalie Boiret-Dupré, Alexandre Janel, Olivier Tournilhac, Eric Hermet, Juliette Berger, Marc G. Berger, Céline Bourgne, Agnès Guerci
Publikováno v:
Leukemia Research. 39:329-334
We investigated Syk as a potential marker of CML progression. We observed a significant over-expression of Syk mRNA and constitutive phosphorylation of Syk Y348 in blast cells from six AP or BP-CML, but not in 15 CML in chronic phase. We could follow
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::004f0ba0c9fa3131cf7fe2d9fd5e8487
https://doi.org/10.1016/j.leukres.2014.11.014
https://doi.org/10.1016/j.leukres.2014.11.014
Autor:
Rima Haddad, Bruno Pereira, Nathalie Boiret-Dupré, Frédérique Dubois-Galopin, Richard Lemal, Céline Bourgne, Marc G. Berger, Céline Lambert, Juliette Berger, Alexandre Janel, Françoise Pflumio, Sara Chabi, Jacques-Olivier Bay, Charlotte Bothorel, Pierre Déchelotte, Eric Hermet
Publikováno v:
American Journal of Hematology
American Journal of Hematology, Wiley, 2017, 92 (10), pp.1020-1031. ⟨10.1002/ajh.24830⟩
American Journal of Hematology, 2017, 92 (10), pp.1020-1031. ⟨10.1002/ajh.24830⟩
American Journal of Hematology, Wiley, 2017, 92 (10), pp.1020-1031. ⟨10.1002/ajh.24830⟩
American Journal of Hematology, 2017, 92 (10), pp.1020-1031. ⟨10.1002/ajh.24830⟩
To understand the complex interactions between hematopoietic stem cells and the bone marrow niche, a human experimental model is needed. Our hypothesis is that hematons are an appropriate ex vivo model of human bone marrow. We analyzed the hierarchic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3086461e98bbe27dcbe21cd6aea9cfc9
https://hal.archives-ouvertes.fr/hal-01655946
https://hal.archives-ouvertes.fr/hal-01655946
Autor:
Marc G. Berger, Juliette Berger, Marie Vigan, Bruno Pereira, Roseline Froissart, Nadia Belmatoug, Florence Dalbies, Agathe Masseau, Christian Rose, Christine Serratrice, Yves-Maris Pers, Ivan Bertschanski, Monia Bengherbia, Céline Bourgne, Alexandre Janel, Catherine Caillaud, Magali Pettazzoni, Amina Berrahal, Jérôme Stirnemann, France Mentré
Publikováno v:
Molecular Genetics and Metabolism. 123:S23-S24
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1d08cd36e6d419cb019aa6e784f7966d
https://doi.org/10.1016/j.ymgme.2017.12.035
https://doi.org/10.1016/j.ymgme.2017.12.035
Autor:
Marc G. Berger, Chantal Rapatel, Laurence Roszyk, Gabrielle Mareynat, Alexandre Janel, Anne-Françoise Serre-Sapin
Publikováno v:
Hematology. 16:123-127
This study evaluates the diagnostic reliability of 11 red blood cells indices, together with our new index, referred to as '11T', in differentiation of beta-thalassemia minor (BTm) from iron deficiency anemia (IDA). A total of 129 patients with micro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::635cb09ad5ee22b53cf1ba7a58af2e5d
https://doi.org/10.1179/102453311x12940641877849
https://doi.org/10.1179/102453311x12940641877849
Autor:
Céline, Bourgne, Alexandre, Janel, Juliette, Berger, Chantal, Rapatel, Olivier, Tournilhac, Eric, Hermet, Agnès, Guerci, Frédérique, Lioret, Aurélie, Briançon, Mahchid, Bamdad, Nathalie, Boiret-Dupré, Marc G, Berger
Publikováno v:
Leukemia research. 39(3)
We investigated Syk as a potential marker of CML progression. We observed a significant over-expression of Syk mRNA and constitutive phosphorylation of Syk Y348 in blast cells from six AP or BP-CML, but not in 15 CML in chronic phase. We could follow
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::7c97356cc5e9da7b61f6cb2d7a497834
https://pubmed.ncbi.nlm.nih.gov/25612940
https://pubmed.ncbi.nlm.nih.gov/25612940
Autor:
Pascale Cony Makhoul, Céline Bourgne, Bruno Pereira, Sylvie Pereira, Denis Guyotat, Mahchid Bamdad, Marie-Claude Gagnieu, Agnès Guerci, Chantal Rapatel, Jean-Yves Cahn, Alexandre Janel, Juliette Berger, Atchroue Johnson Ansah, Marc G. Berger, Frédéric Libert, Sébastien Trouillier, Eric Hermet, Nathalie Boiret-Dupré, Pascale Pigeon
Publikováno v:
Cytometry Part A
Cytometry Part A, Wiley, 2012, 81 (11), pp.996-1004. ⟨10.1002/cyto.a.22118⟩
Cytometry Part A, Wiley, 2012, 81 (11), pp.996-1004. ⟨10.1002/cyto.a.22118⟩
International audience; One of the essential parameters of targeted therapy efficiency in cancer treatment is the amount of drug reaching the therapeutic target area. Imatinib (IM) was the first specifically targeted drug to be developed and has revo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::67fcaed86604c0f1191847d081f18cdb
https://hal.archives-ouvertes.fr/hal-00849687
https://hal.archives-ouvertes.fr/hal-00849687